Dr. Fesko: "It's central. Having been directly involved in patient care, I understand the clinical challenges physicians face daily. This perspective helps me ensure that Quest's diagnostics are not only innovative but also practical and impactful in real-world clinical settings."
Dr. Fesko: "I think we're on the verge of transformative applications of real-world evidence (RWE), particularly in oncology. The ability to integrate patient data from varied sources and apply it to treatment decisions could really change the way we approach individualized care."
Dr. Fesko: "I'm an activate participant in the field, attending conferences and engaging with the latest research. I also value the continous collaboration with Quest's research and development teams, where we explore new technologies and innovations that shape the future of diagnostics."
Dr. Fesko: "Despite my demanding schedule, I always make time to disconnect and explore the outdoors with my family. We love visiting national parks, and it's a great way to recharge while spending time together."
The escalating global challenge of oncology care demands new approaches to detection, diagnosis, and treatment.
This white paper is free and can be downloaded and read at your convenience.
Curious about emerging trends in oncology diagnostics? Wondering how companion diagnostics could support your clinical trial? Submit your question to Dr. Fesko, and he'll respond with insights based on his extensive expertise in precision medicine and clinical practice.
Responses provided within 48 hours. Your questions will be answered directly and privately. Some frequently asked questions may also be shared on this page with your permission, adding to our "Insights from Dr. Fesko" section.
Dr. Yuri Fesko, Chief Medical Officer at Quest Diagnostics, combines his experience as a practicing oncologist with a strategic focus on advancing diagnostics. With deep expertise in oncology, hematology, and internal medicine, Dr. Fesko brings a clinician's insight to Quest's medical affairs and clinical development, championing innovations like the 500-gene somatic tumor panel and decentralized trial models.
Born and raised in New York City, Dr. Fesko remains closely connected to his community, where he and his wife reside. Outside of work, he's an avid hiker and enjoys exploring national parks with his family. Known for his collaborative spirit, Dr. Fesko believes that each patient deserves diagnostics that drive better outcomes — and he's dedicated to making that vision a reality.
